4-(Dimethylamino)-4-methylpent-2-ynoic acid hydrochloride

Catalog No.: 
ACRISU540
CAS No.: 
2595201-64-0
Molecular Formula: 
C8H14ClNO2
Molecular Weight: 
191.66
4-(Dimethylamino)-4-methylpent-2-ynoic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$248.00In stockIn stock
250mg95%$416.00In stockIn stock
1g95%$818.00In stockIn stock
5g95%$2827.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Dimethylamino)-4-methylpent-2-ynoic acid hydrochloride
IUPAC Name4-(dimethylamino)-4-methylpent-2-ynoic acid hydrochloride
Molecular FormulaC8H14ClNO2
Molecular Weight191.66
SMILESCC(C)(N(C)C)C#CC(O)=O.[H]Cl
InChI KeyZRBCPNQUSNHQMH-UHFFFAOYSA-N
Synonym2-Pentynoic acid, 4-(dimethylamino)-4-methyl-, hydrochloride (1:1);4-(Dimethylamino)-4-methyl-2-pentynoic acid (hydrochloride);4-(Dimethylamino)-4-methylpent-2-ynoic acid hydrochloride
CAS No.2595201-64-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACRISU540 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRISU540 route product structure diagram
    ACRISU5402595201-64-0In Stock
Inquiry

2. ACRISU540 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRISU540 route product structure diagram
    ACRISU5402595201-64-0In Stock
Inquiry

3. ACRISU540 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRISU540 route product structure diagram
    ACRISU5402595201-64-0In Stock
Inquiry

Comments (0)